Turmeric supplementation could be an adjuvant to T2DM on metformin treatment having a beneficial effect on blood glucose, oxidative stress and inflammation.
Efficacy of Turmeric as Adjuvant Therapy in Type 2 Diabetic Patients.
AI Summary
Key Findings
Abstract
It is known that there is a significant interplay of insulin resistance, oxidative stress, dyslipidemia, and inflammation in type 2 diabetes mellitus (T2DM). The study was undertaken to investigate the effect of turmeric as an adjuvant to anti-diabetic therapy. Sixty diabetic subjects on metformin therapy were recruited and randomized into two groups (30 each). Group I received standard metformin treatment while group II was on standard metformin therapy with turmeric (2 g) supplements for 4 weeks. The biochemical parameters were assessed at the time of recruitment for study and after 4 weeks of treatment. Turmeric supplementation in metformin treated type 2 diabetic patient significantly decreased fasting glucose (95 ± 11.4 mg/dl, P
Affiliation
N Maithili Karpaga Selvi
External References
- PubMed ID:
- 25883426
Comments
Sign in or create a free account to join the conversation.
Sign in to commentBe the first to comment.